PTC Therapeutics secures FDA approval for Sephience in PKU, launching August with analysts projecting strong revenue and ...

As previously reported, William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform after the company reported Q2 results and cut ...

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing ...

Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for ...

William Blair downgraded NeoGenomics (NEO) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, ...

Sarepta Therapeutics shares jumped over 36% on Tuesday after the company said it had received FDA approval to restart ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...

Manhattan Associates delivered a positive Q2, with the market responding strongly to the company's better-than-expected results. Management attributed the quarter’s outperformance to robust growth in ...

NIQ Global Intelligence is looking to raise $1.05bn in an initial public offering on the New York Stock Exchange.

Palantir Technologies Inc. (NASDAQ:PLTR) ranks among the best momentum stocks to buy. Palantir Technologies Inc. (NASDAQ:PLTR) was awarded a $100 million contract by the U.S. Army to the ...